Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bock

Showing results (171-180 of 202) with videos related to

Pageof 21
Sort By:
Chemmedchem|November 14, 2014
From ergolines to indoles: improved inhibitors of the human H3 receptor for the treatment of narcolepsyYves P Auberson, Thomas Troxler, Xuechun Zhang, et al.
Biochemical and Biophysical Research Communications|April 23, 2005
Binding modes of dihydroquinoxalinones in a homology model of bradykinin receptor 1Sookhee N Ha, Pat J Hey, Rick W Ransom, et al.
Chemmedchem|May 23, 2014
Ergoline-derived inverse agonists of the human h3 receptor for the treatment of narcolepsyYves P Auberson, Thomas Troxler, Xuechun Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Nonpeptide oxytocin antagonists: potent, orally bioavailable analogs of L-371,257 containing a 1-R-(pyridyl)ethyl ether terminusM S Kuo, M G Bock, R M Freidinger, et al.
Bioorganic & Medicinal Chemistry Letters|February 2, 2008
A new class of bradykinin B1 receptor antagonists with high oral bioavailability and minimal PXR activityDong-Mei Feng, Robert M DiPardo, Jenny M Wai, et al.
Bioorganic & Medicinal Chemistry Letters|March 15, 2006
5-Piperazinyl pyridine carboxamide bradykinin B1 antagonistsScott D Kuduk, Christina Ng Di Marco, Ronald K Chang, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2005
2,3-Diaminopyridine as a platform for designing structurally unique nonpeptide bradykinin B1 receptor antagonistsDong-Mei Feng, Jenny M Wai, Scott D Kuduk, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2009
Amiloride derived inhibitors of acid-sensing ion channel-3 (ASIC3)Scott D Kuduk, Christina N Di Marco, Ronald K Chang, et al.
Nature|January 5, 2001
Subduction and collision processes in the Central Andes constrained by converted seismic phasesX Yuan, S V Sobolev, R Kind, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2007
Potent bradykinin B1 receptor antagonists: 4-substituted phenyl cyclohexanesDai-Shi Su, John L Lim, M Kristine Markowitz, et al.
Pageof 21

Showing results (171-180 of 202) with videos related to

Sort By:
Pageof 21
Chemmedchem|November 14, 2014
From ergolines to indoles: improved inhibitors of the human H3 receptor for the treatment of narcolepsyYves P Auberson, Thomas Troxler, Xuechun Zhang, et al.
Biochemical and Biophysical Research Communications|April 23, 2005
Binding modes of dihydroquinoxalinones in a homology model of bradykinin receptor 1Sookhee N Ha, Pat J Hey, Rick W Ransom, et al.
Chemmedchem|May 23, 2014
Ergoline-derived inverse agonists of the human h3 receptor for the treatment of narcolepsyYves P Auberson, Thomas Troxler, Xuechun Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Nonpeptide oxytocin antagonists: potent, orally bioavailable analogs of L-371,257 containing a 1-R-(pyridyl)ethyl ether terminusM S Kuo, M G Bock, R M Freidinger, et al.
Bioorganic & Medicinal Chemistry Letters|February 2, 2008
A new class of bradykinin B1 receptor antagonists with high oral bioavailability and minimal PXR activityDong-Mei Feng, Robert M DiPardo, Jenny M Wai, et al.
Bioorganic & Medicinal Chemistry Letters|March 15, 2006
5-Piperazinyl pyridine carboxamide bradykinin B1 antagonistsScott D Kuduk, Christina Ng Di Marco, Ronald K Chang, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2005
2,3-Diaminopyridine as a platform for designing structurally unique nonpeptide bradykinin B1 receptor antagonistsDong-Mei Feng, Jenny M Wai, Scott D Kuduk, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2009
Amiloride derived inhibitors of acid-sensing ion channel-3 (ASIC3)Scott D Kuduk, Christina N Di Marco, Ronald K Chang, et al.
Nature|January 5, 2001
Subduction and collision processes in the Central Andes constrained by converted seismic phasesX Yuan, S V Sobolev, R Kind, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2007
Potent bradykinin B1 receptor antagonists: 4-substituted phenyl cyclohexanesDai-Shi Su, John L Lim, M Kristine Markowitz, et al.
Pageof 21